1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Celltrion, Inc.
  6. Financials
    A068270   KR7068270008

CELLTRION, INC.

(A068270)
  Report
End-of-day quote Korea Stock Exchange  -  2022-08-15
211000.00 KRW   +1.44%
08/15Infliximab Clinical Trial Updates
AQ
08/09Celltrion Files IND With FDA For Adalimumab Biosimilar
AQ
08/07Celltrion's Net Income Jumps 41.2% in June Quarter
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 24 175 55248 989 35127 592 58329 071 446--
Enterprise Value (EV)2 24 04749 09027 11728 31628 17927 614
P/E ratio 77,7x94,4x47,2x49,5x40,2x29,8x
Yield --0,38%0,26%0,27%0,28%
Capitalization / Revenue 21,4x26,5x14,6x12,7x11,5x9,47x
EV / Revenue 21,3x26,5x14,3x12,3x11,1x8,99x
EV / EBITDA 44,8x55,1x27,9x29,5x24,1x18,7x
Price to Book 8,27x14,4x6,87x6,88x5,93x5,06x
Nbr of stocks (in thousands) 138 963139 190139 356137 779--
Reference price (KRW) 173 972351 961198 000211 000211 000211 000
Announcement Date 02/19/202002/22/202102/16/2022---
1 KRW in Million
2 KRW in Billions
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1 1281 8491 8912 2972 5303 071
EBITDA1 5378919729591 1671 479
Operating profit (EBIT)1 3787127547539491 214
Operating Margin 33,5%38,5%39,9%32,8%37,5%39,5%
Pre-Tax Profit (EBT)1 3796517477649551 295
Net income1 2985115755977431 012
Net margin 26,4%27,7%30,4%26,0%29,4%32,9%
EPS2 2 2403 7294 1924 2615 2527 077
Dividend per Share2 --750550580600
Announcement Date 02/19/202002/22/202102/16/2022---
1 KRW in Billions
2 KRW
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 401601551596572658
EBITDA ------
Operating profit (EBIT)1 164219142199205220
Operating Margin 40,9%36,4%25,8%33,4%35,8%33,4%
Pre-Tax Profit (EBT)1 188145-227229270
Net income1 135120119183167150
Net margin 33,8%20,0%21,5%30,8%29,2%22,8%
EPS ------
Dividend per Share ------
Announcement Date 11/10/202102/16/202205/12/202208/05/2022--
1 KRW in Billions
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 -100----
Net Cash position1 128-4767558921 458
Leverage (Debt / EBITDA) -0,24x0,11x-0,49x-0,79x-0,76x-0,99x
Free Cash Flow2 379 716263 739589 594426 260462 417746 250
ROE (Net Profit / Equities) 11,2%16,7%16,5%13,7%15,0%17,3%
Shareholders' equity1 2 6563 0653 4864 3494 9485 845
ROA (Net Profit / Asset) 8,02%11,6%10,7%9,72%10,8%13,3%
Assets1 3 7134 4025 3726 1436 8767 626
Book Value Per Share3 21 02624 44128 84130 65035 55741 662
Cash Flow per Share3 3 5672 5596 6736 9548 2129 973
Capex1 94,387,063,493,0196127
Capex / Sales 8,35%4,71%3,35%4,05%7,76%4,14%
Announcement Date 02/19/202002/22/202102/16/2022---
1 KRW in Billions
2 KRW in Million
3 KRW
Previous periodNext period
Estimates
Key data
Capitalization (KRW) 29 071 445 593 000
Capitalization (USD) 22 158 958 492
Net sales (KRW) 1 890 821 000 000
Net sales (USD) 1 441 229 468
Number of employees 2 034
Sales / Employee (KRW) 929 607 178
Sales / Employee (USD) 708 569
Free-Float 74,8%
Free-Float capitalization (KRW) 21 735 169 266 193
Free-Float capitalization (USD) 16 567 071 357
Avg. Exchange 20 sessions (KRW) 97 239 561 000
Avg. Exchange 20 sessions (USD) 74 118 344
Average Daily Capital Traded 0%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA